Serif Biomedicines News and Activities

Acquisition, funding and merger involving Serif Biomedicines.

• Serif Biomedicines has just announced a $50 Million fundraising (posted on April 29 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Serif Biomedicines

• Jacob Rubens, Chief Exec­u­tive Officer
• Avak Kahve­jian, Direc­tor
• Geof­frey von Maltzahn, Chairman of the Board

Create your alert
to follow the executive moves at Serif Biomedicines.

Serif Biomedicines has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Serif Biomedicines

Social media about Serif Biomedicines

• Serif Biomedicines on Wikipedia, Google News & Yahoo Finance
• Serif Biomedicines on LinkedIn, X (Twitter) & YouTube